CATALOGO DEI PRODOTTI DELLA RICERCA

CINGARLINI, Sara
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.527
NA - Nord America 3.981
AS - Asia 2.622
SA - Sud America 373
AF - Africa 48
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 11.563
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.888
RU - Federazione Russa 1.606
CN - Cina 1.099
GB - Regno Unito 981
SG - Singapore 862
IT - Italia 453
SE - Svezia 324
BR - Brasile 308
DE - Germania 308
IE - Irlanda 263
HK - Hong Kong 251
FR - Francia 211
FI - Finlandia 166
VN - Vietnam 124
KR - Corea 59
CA - Canada 54
JP - Giappone 43
TR - Turchia 43
NL - Olanda 39
IN - India 38
UA - Ucraina 36
BE - Belgio 29
ES - Italia 25
MX - Messico 24
AR - Argentina 22
PL - Polonia 20
ID - Indonesia 19
AT - Austria 16
BD - Bangladesh 16
IR - Iran 15
ZA - Sudafrica 15
IQ - Iraq 11
AE - Emirati Arabi Uniti 9
VE - Venezuela 9
CL - Cile 8
LV - Lettonia 8
AU - Australia 7
LT - Lituania 7
AZ - Azerbaigian 6
CH - Svizzera 6
EC - Ecuador 6
MA - Marocco 6
CO - Colombia 5
EG - Egitto 5
PE - Perù 5
PH - Filippine 5
UY - Uruguay 5
BJ - Benin 4
CZ - Repubblica Ceca 4
JM - Giamaica 4
TG - Togo 4
UZ - Uzbekistan 4
DZ - Algeria 3
IL - Israele 3
KE - Kenya 3
MK - Macedonia 3
PY - Paraguay 3
AL - Albania 2
BY - Bielorussia 2
CM - Camerun 2
DK - Danimarca 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
JO - Giordania 2
KZ - Kazakistan 2
NI - Nicaragua 2
NO - Norvegia 2
PA - Panama 2
RO - Romania 2
SA - Arabia Saudita 2
SI - Slovenia 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
BO - Bolivia 1
CR - Costa Rica 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
ME - Montenegro 1
MQ - Martinica 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
PW - Palau 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TJ - Tagikistan 1
Totale 11.562
Salva come PNG Salva come JPEG
Città #
Southend 866
Chandler 614
Moscow 604
Dallas 561
Singapore 346
Ashburn 319
Dublin 254
Hong Kong 245
Jacksonville 245
Beijing 225
Ann Arbor 214
Woodbridge 204
Verona 140
New York 126
Houston 95
Los Angeles 86
Munich 84
Jinan 76
Lawrence 76
Princeton 76
Wilmington 72
Shenyang 70
Helsinki 60
Nanjing 53
The Dalles 53
Tianjin 53
São Paulo 50
Ho Chi Minh City 44
Hebei 40
Tokyo 37
Changsha 35
Milan 35
Columbus 34
Haikou 34
Redmond 32
Guangzhou 31
Redondo Beach 31
Zhengzhou 31
Brussels 29
Santa Clara 29
Seattle 25
Bologna 24
Sindelfingen 24
Buffalo 23
Montreal 23
Nanchang 23
Taiyuan 23
Hangzhou 22
London 22
Seoul 22
Turku 22
Denver 21
Ningbo 20
Taizhou 20
Lancaster 19
Redwood City 19
Hanoi 18
San Francisco 17
Warsaw 17
Chicago 16
Falkenstein 16
Jiaxing 15
Brooklyn 14
Orem 14
Chennai 13
Kent 13
Poplar 13
Shanghai 13
Stockholm 13
Toronto 13
Boardman 12
Council Bluffs 12
Dong Ket 12
Amsterdam 11
Frankfurt am Main 11
Mexico City 11
Phoenix 11
Washington 11
Curitiba 10
Fuzhou 10
Jakarta 10
Johannesburg 10
Rio de Janeiro 10
Brescia 9
Norwalk 9
Nuremberg 9
Belo Horizonte 8
Dearborn 8
Manchester 8
Rome 8
Atlanta 7
Lappeenranta 7
Baku 6
Desenzano del Garda 6
Düsseldorf 6
Genova 6
Leawood 6
Mumbai 6
New Delhi 6
Salvador 6
Totale 7.128
Salva come PNG Salva come JPEG
Nome #
Whole-genome landscape of pancreatic neuroendocrine tumours 245
Anti-tumor effects of toxins targeted to the prostate specific membrane antigen. 234
Anti PSMA immunotoxins activity against prostate cancer cell lines. 232
Acquired hemophagocytic syndrome in a patient with synovial sarcoma: a case report 212
Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors? 201
Apical transport and folding of prostate-specific membrane antigen occurs independent of glycan processing. 198
Are Cystic Pancreatic Neuroendocrine Tumors an Indolent Entity? Results from a Single-Center Surgical Series 197
The Evolution of Surgical Strategies for Pancreatic Neuroendocrine Tumors (Pan-NENs): Time-trend and Outcome Analysis From 587 Consecutive Resections at a High-volume Institution. 197
Anti PSCA Monoclonal Antibody and scFv-Fragment for Immunotherapy of Prostate, Pancreatic and Bladder Carcinoma 196
3D-CT texture analysis of neuroendocrine pancreatic neoplasms 190
Characterization of a new anti PSCA monoclonal antibody and scFv fragment for diagnosis and immunotherapy of prostate, pancreatic and bladder carcinoma. 184
A prospective non-randomised single-center study comparing laparoscopic and robotic distal pancreatectomy 183
Perfusion Changes in Liver Metastases (LM) from Pancreatic Neuroendocrine Tumors (PanNETs) during Everolimus (E) Treatment: Update of Perfusion CT (P-CT) Study 181
Anticorpo monoclonale isolato o suo frammento legante l'antigene specifico di membrana della prostata, suoi coniugati e suoi usi 178
A single-chain fragment against prostate specific membrane antigen as a tool to build theranostic reagents for prostate cancer 177
IFN-gamma-mediated upmodulation of MHC class I expression activates tumor-specific immune response in a mouse model of prostate cancer 175
Comparison of imaging-based and pathological dimensions in pancreatic neuroendocrine tumors 174
Anti-prostate specific membrane antigen targeted gold nanoparticles in tumor therapy and diagnosis 173
CT Enhancement and 3D Texture Analysis of Pancreatic Neuroendocrine Neoplasms 170
EpCAM a possible target for immunotoxin treatments of PSMA positive and negative prostate cancer cells 169
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 167
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumours 166
Mixed adenoneuroendocrine carcinomas of the gastrointestinal tract: targeted next-generation sequencing suggests a monoclonal origin of the two components 165
Ingegnerizzazione di un vettore per espressione di frammenti anticorpali (scFv) biotinilati in procarioti, purificazione ed analisi funzionale 164
Adjuvant Chemotherapy For Resected Non-Small-Cell Lung Cancer: Future Perspectives For Clinical Research 163
Production of a biotinylated anti-PSMA single-chain antibody fragment (scFv) for imaging and radioimmunotherapy 162
The prostate specific membrane antigen regulates the expression of IL-6 and CCL5 in prostate tumor cells by activating the MAPK pathways. 162
Tumor Targeting with Guided Silica Nanopartilces for Prostate Cancer Therapy 158
Pancreatic neuroendocrine neoplasms: Magnetic resonance imaging features according to grade and stage 157
Investigation of Properties of Anti-Prostate Specific Membrane Antigen-targeted Gold Nanoparticles as Drug Carriers in Tumor Therapy 156
The prostate specific membrane antigen regulates the expression of IL-6 and CCL-5 in prostate tumour cells by activating the MAPK pathways 156
Perfusion CT Changes in Liver Metastases from Pancreatic Neuroendocrine Tumors During Everolimus Treatment 156
Role of Combined Ga-68-DOTATOC and F-18-FDG Positron Emission Tomography/Computed Tomography in the Diagnostic Workup of Pancreas Neuroendocrine Tumors Implications for Managing Surgical Decisions 155
Dual-tracer (68Ga-DOTATOC and 18F-FDG-)-PET/CT scan and G1-G2 non-functioning pancreatic neuroendocrine tumors: A single-center retrospective evaluation of 124 non-metastatic resected cases 155
Produzione e validazione preclinica di un anticorpo anti-PSMA per diagnostica ed immunotargeting 154
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice? 154
Liver Tumor Burden in Pancreatic Neuroendocrine Tumors: CT Features and Texture Analysis in the Prediction of Tumor Grade and 18F-FDG Uptake 153
Organisational challenges, volumes of oncological activity and patients' perception during the severe acute respiratory syndrome coronavirus 2 epidemic 153
ESGAR 2016 Book of Abstracts 152
Generazione di nuovi anticorpi anti prostate stem cell antigen (PSCA) e loro caratterizzazione al fine di un futuro utilizzo nella terapia e nella diagnosi dei carcinomi prostatico, pancreatico e della vescica 148
Pathological complete response in a patient affected by multiple synchronous, breast and lung primary malignancies: a case report and review of the literature 148
Prognostication and response assessment in liver and pancreatic tumors: The new imaging 148
The development of PARP as a successful target for cancer therapy 146
Tumor Perfusion Changes During Everolimus (E) Treatment: Preliminary Results from Perfusion-CT (P-CT) Study 135
Pancreatic neuroendocrine neoplasms: MRI features and correlation with their histological grade 133
Clinical and Genomic Characterization of Pancreatic Ductal Adenocarcinoma with Signet-Ring/Poorly Cohesive Cells 131
Endoscopic ultrasound-guided fine-needle aspiration for the diagnosis and grading of pancreatic neuroendocrine tumors: a retrospective analysis of 110 cases 131
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours 130
Platinum-Based Treatment for Well- and Poorly Differentiated Pancreatic Neuroendocrine Neoplasms 130
Digital Subtraction of Magnetic Resonance Images Improves Detection and Characterization of Pancreatic Neuroendocrine Neoplasms 129
Imaging presentation of pancreatic neuroendocrine neoplasms 129
Patterns of recurrence after resection for pancreatic neuroendocrine tumors: who, when, and where? 129
Multi-institutional Development and External Validation of a Nomogram to Predict Recurrence After Curative Resection of Pancreatic Neuroendocrine Tumors 129
Isolated monoclonal antibody or fragment thereof binding prostate specific membrane antigen, conjugates and uses thereof 124
Efficacy and Toxicity Analysis of mFOLFIRINOX in High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms 123
Prognostic Stratification and Therapeutic Response Assessment in Liver and Pancreatic Tumors: the New Imaging 122
Solid non-functioning endocrine tumors of the pancreas: correlating computed tomography and pathology 121
Histogram analysis of ADC maps: assessment of intra-tumoral heterogeneity and correlation with the biological behavior of pancreatic neuroendocrine neoplasms 120
Preclinical studies of a new anti-psma (prostate specific membrane antigen) antibody for diagnosis and immunotargeting 117
Clinical presentation, genotype-phenotype correlations, and outcome of pancreatic neuroendocrine tumors in Von Hippel-Lindau syndrome 117
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants 117
Pulmonary Adenocarcinoma With Enteric Differentiation: Immunohistochemistry and Molecular Morphology 116
Streptozotocin/5-Fluorouracil (STZ/5FU) Chemotherapy in G1-G2 Pancreatic Neuroendocrine Tumors (pNETs): Single Institution Experience 113
DNA methylation patterns identify subgroups of pancreatic neuroendocrine tumors with clinical association 112
Is Laparoscopic CME Right Hemicolectomy an Optimal Indication for NET of the Right Colon and Terminal Ileum? 108
Minimally Invasive Surgery for Pancreatic Neuroendocrine Tumors: Why Not? 107
Surgery for pancreatic neuroendocrine tumors during the COVID-19 pandemic: a retrospective cohort from a high-volume center 106
Profiling mTOR pathway in neuroendocrine tumors 106
Suppression of mTOR pathway in solid tumors: lessons learned from clinical experience in renal cell carcinoma and neuroendocrine tumors and new perspectives 104
Differentiation of pancreatic neuroendocrine tumor grade comparing 3D CT texture analysis and relative CT enhancement ratios 104
Pancreatic Neuroendocrine Neoplasms: Clinical Value of Diffusion-Weighted Imaging 102
Ultra-Mutation in IDH Wild-Type Glioblastomas of Patients Younger than 55 Years is Associated with Defective Mismatch Repair, Microsatellite Instability, and Giant Cell Enrichment 102
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models 101
Ki-67 assessment of pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis of manual vs. digital pathology scoring 96
Normal Tissue Perfusion Changes During Everolimus Treatment: Preliminary Results from a Functional Vascular Study 85
Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size 79
Mutational and copy number asset of primary sporadic neuroendocrine tumors of the small intestine 78
Glucagon-Producing Pancreatic Neuroendocrine Tumors (Glucagonomas) are Enriched in Aggressive Neoplasms with ARX and PDX1 Co-expression, DAXX/ATRX Mutations, and ALT (Alternative Lengthening of Telomeres) 73
Pattern of disease recurrence and treatment after surgery for nonfunctioning well-differentiated pancreatic neuroendocrine tumors 72
Transcriptome analysis of primary sporadic neuroendocrine tumours of the intestine identified three different molecular subgroups 70
Somatostatin analogs for resectable pancreatic neuroendocrine tumors in high-risk surgical patients: Data from a single-center cohort 63
Is the Morphological Subtype of Extra-Pulmonary Neuroendocrine Carcinoma Clinically Relevant? 58
Clinical practice guidelines for the management of non-functioning advanced GEP-NENs: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology (AIOM) in collaboration with the Italian Association for Neuroendocrine Tumors (ITANET) 24
Totale 11.710
Salva come PNG Salva come JPEG
Categoria #
all - tutte 39.467
article - articoli 26.874
book - libri 0
conference - conferenze 10.970
curatela - curatele 0
other - altro 436
patent - brevetti 825
selected - selezionate 0
volume - volumi 362
Totale 78.934
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021331 0 0 0 0 82 50 14 37 41 17 62 28
2021/2022786 65 256 18 70 37 17 14 44 23 18 53 171
2022/20231.625 96 211 148 287 108 429 38 88 173 9 25 13
2023/2024835 29 66 75 82 90 166 25 50 9 65 144 34
2024/20251.933 104 112 108 273 99 76 104 88 279 137 182 371
2025/20263.694 412 354 507 1.112 1.309 0 0 0 0 0 0 0
Totale 11.710